Volume | 26,043 |
|
|||||
News | - | ||||||
Day High | 4.17 | Low High |
|||||
Day Low | 3.75 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Neuronetics Inc | STIM | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
3.75 | 3.75 | 4.17 | 3.74 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
798 | 26,043 | $ 3.83 | $ 99,708 | - | 1.03 - 5.0699 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
13:52:18 | 5 | $ 3.85 | USD |
Neuronetics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
113.07M | 29.76M | - | 71.35M | -30.19M | -1.01 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Neuronetics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical STIM Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 4.14 | 4.183 | 3.69 | 3.84 | 47,583 | -0.31 | -7.49% |
1 Month | 4.75 | 5.0699 | 3.69 | 4.32 | 139,909 | -0.92 | -19.37% |
3 Months | 3.30 | 5.0699 | 2.77 | 3.88 | 177,424 | 0.53 | 16.06% |
6 Months | 1.09 | 5.0699 | 1.03 | 3.17 | 171,528 | 2.74 | 251.38% |
1 Year | 2.20 | 5.0699 | 1.03 | 2.66 | 155,012 | 1.63 | 74.09% |
3 Years | 11.30 | 17.92 | 1.03 | 5.74 | 284,277 | -7.47 | -66.11% |
5 Years | 15.41 | 22.43 | 1.03 | 6.08 | 307,286 | -11.58 | -75.15% |
Neuronetics Description
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options. |